FWM
MBIO icon

Frontier Wealth Management’s Mustang Bio MBIO Stock Holding History

Frontier Wealth Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-67
Closed -$163K – 317
2019
Q3 		$163K Buy
67
+28
+72% +$76.6K 0.02% 289
2019
Q2 		$109K Hold
39
– – 0.02% 294
2019
Q1 		$101K Buy
39
+5
+15% +$14.2K 0.01% 350
2018
Q4 		$75K Hold
34
– – 0.01% 349
2018
Q3 		$152K Hold
34
– – 0.01% 372
2018
Q2 		$176K Hold
34
– – 0.03% 362
2018
Q1 		$279K Buy
+34
New +$290K 0.04% 311

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Frontier Wealth Management's MBIO Position: Q4 2019 in Review

Frontier Wealth Management sold out of Mustang Bio (MBIO) in Q4 2019, closing a stake of 67 shares — an estimated $163K sold.

Frontier Wealth Management first reported a position in MBIO in Q1 2018 and held it in 7 quarters. The position peaked at $279K in Q1 2018. 55 funds tracked by Wall St. Rank hold MBIO as of Q4 2019.

  • Frontier Wealth Management reported no remaining Mustang Bio position as of Q4 2019 after selling out during the quarter.
  • Frontier Wealth Management sold 67 Mustang Bio shares in Q4 2019, an estimated $163K.
  • Frontier Wealth Management first reported a position in Mustang Bio in Q1 2018 and held it in 7 quarters.
  • Frontier Wealth Management's Mustang Bio position peaked at $279K in Q1 2018.
  • 55 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2019.

Based on Frontier Wealth Management's 13F filing for Q4 2019, filed 13 Feb 2020.